<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE topic
  PUBLIC "-//IFRS//DTD DITA Topic//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/ifrsTopic.dtd">
<topic id="IAS38_0003"><title id="IAS38_0003_TI" base="SL142076" level="1" outputclass="no_rule">Example 2&#x2002;An acquired patent that expires in 15 years</title><body><p id="IAS38_P0401" base="SL142077">The product protected by the patented technology is expected to be a source of net cash inflows for at least 15 years. The entity has a commitment from a third party to purchase that patent in five years for 60 per cent of the fair value of the patent at the date it was acquired, and the entity intends to sell the patent in five years.</p><p id="IAS38_P0402" base="SL142078">The patent would be amortised              over its five&#x2011;year useful life              to the entity, with a residual value              equal to the present value of 60 per cent of the patent&#x2019;s fair value at the date it was acquired. The patent would also be reviewed for impairment in accordance with <xref id="IAS38_X0466" base="F16456475" href="../ias36/IAS36_TOC0001.dita#IAS36_TOC0001">IASÂ 36</xref> by assessing at the end of each reporting period whether there is any indication that it may be impaired.            </p></body></topic>